Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Liver Failure × Glycyrrhizic Acid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Liver Failure 1 Carcinoma, Hepatocellular 1

Interventions

urinastatin 1 sacituzumab govitecan 1 maltodextrin 1 halofantrine 1 Raltegravir Potassium 1 N-monoacetylcystine 1 Glycyrrhizic Acid 1 Everolimus 1 Amino Acids 1 Acetylcysteine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01643447 2016-03-31

Ulinastatin Preventing Postoperative Hepatic Failure in Hepatocellular Carcinoma (HCC)

Eastern Hepatobiliary Surgery Hospital

Phase NA Completed

Gastrointestinal

Carcinoma, Hepatocellular, Liver Failure

Data powered by HemOnc (CC BY 4.0) Colophon ⚡